$NASDAQ:LNTH

Chief Accounting Officer of Lantheus Holdings Sells 386 Shares
Gallery

Chief Accounting Officer of Lantheus Holdings Sells 386 Shares

Trending News ☀️ Lantheus Holdings ($NASDAQ:LNTH) Inc. is a global leader in the development, manufacture, and commercialization of diagnostic imaging [...]

By GoodWhale|January 30, 2023|Categories: Drug Manufacturers - Specialty & Generic|Tags: $NASDAQ:LNTH, Drug Manufacturers - Specialty & Generic, NASDAQ|0 Comments

Lantheus Holdings Celebrates Successful Patient Randomization in Phase 3 SPLASH Trial of PNT2002.
Gallery

Lantheus Holdings Celebrates Successful Patient Randomization in Phase 3 SPLASH Trial of PNT2002.

Trending News ☀️ Lantheus Holdings ($NASDAQ:LNTH) (NASDAQ: LNT) is a global leader in the development, manufacture and commercialization of diagnostic [...]

By GoodWhale|January 14, 2023|Categories: Drug Manufacturers - Specialty & Generic|Tags: $NASDAQ:LNTH, Drug Manufacturers - Specialty & Generic, NASDAQ|0 Comments

Shares of Lantheus Holdings Plunge by 28.6%

Trending News ☀️ Shares of Lantheus Holdings ($NASDAQ:LNTH), a medical imaging company, have recently taken a dramatic plunge. The company [...]

By GoodWhale|December 21, 2022|Categories: Drug Manufacturers - Specialty & Generic|Tags: $NASDAQ:LNTH, Drug Manufacturers - Specialty & Generic, NASDAQ|0 Comments

Baird Financial Group Takes Position in Lantheus Holdings,

Trending News 🌥️ Baird Financial Group Inc. has taken a position in Lantheus Holdings ($NASDAQ:LNTH), Inc. Lantheus is a leading [...]

By GoodWhale|November 24, 2022|Categories: Drug Manufacturers - Specialty & Generic|Tags: $NASDAQ:LNTH, Drug Manufacturers - Specialty & Generic, NASDAQ|0 Comments

Lantheus Holdings Expected to Report Strong Top-Line Results for Third Quarter

Trending News ☀️ Lantheus Holdings ($NASDAQ:LNTH) is a specialty pharmaceutical company focused on developing and commercializing novel diagnostic and therapeutic [...]